Key Points- Big pharmaceutical companies like Bristol Myers Squibb, Merck and Johnson & Johnson face so-called patent cliffs that will put tens of billions of dollars in sales at risk between now and 2030.- That refers to when patents expire for one or more leading branded products for a company, which opens up the door […]
